INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampullary Cancer
Status:
Recruiting
Trial end date:
2028-08-01
Target enrollment:
Participant gender:
Summary
Phase 2 study to evaluate the clinical activity of INCMGA00012 in patients with Unresectable
or metastatic Adenosquamous Pancreatic or Ampullary Cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins